RRRiham Hazem Raafat

Riham Hazem Raafat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Riham Hazem Raafat has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • A. Saber Abdel-Rehim

    Department of Internal Medicine, Allergy and Clinical immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Ahmad Madkour

    Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt

    1 shared publication
  • Ahmed Ibrahim El-Sayed Ibrahim

    Department of Internal Medicine and Nephrology, Faculty of Medicine – Ain Shams University

    1 shared publication
  • Dina Sayed Sheha

    Department of Internal Medicine, Allergy and Clinical Immunology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Dina Sayed Sheha

    Department of Internal Medicine, Allergy and Clinical immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Heba Eid AbuAlia

    Department of Internal Medicine, Allergy and Clinical Immunology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Non-invasive predictors of ICU admission and mortality in initially asymptomatic COVID-19 patients

    by Riham Hazem Raafat, Mohamed Alboraie, Sally Waheed Elkhadry, Mostafa Abdelnasier, Mohamed Ahmed Hashish, Yahya Ahmed Almansoury, Noha Yousef, Omar Elshaarawy, Ahmad Madkour

    Background: Coronavirus disease 2019 (COVID-19) can present with pulmonary and non-pulmonary manifestations, or it may be asymptomatic. Asymptomatic patients have a major impact on transmission of the disease, and prediction of their outcome and prognosis is challenging. We aim to identify the predictors of intensive care unit (ICU) admission and mortality in hospitalized COVID-19 patients with initially asymptomatic presentation. Methods: This was a prospective multicenter study using cohort data that included all admitted patients aged 21 years and above, with different clinical presentations other (than pulmonary manifestation) and were discovered to have COVID-19. Demographic data, clinical data and progression were reported. Univariate analysis and logistic regression analysis were performed to predict ICU admission and mortality during hospitalization. Results: One hundred forty-nine consecutive patients, 92 (61.7% males) were included in our study, Median age (IQR) was 59.00 (43–69]. Only 1 patient (0.7%) had a contact with a confirmed case of COVID-19. 58 patients (39%) were admitted to ICU and 22 patients (14.8%) have died. High ferritin level (more than 422.5), low oxygen saturation (less than 93%), and in need of non-invasive ventilation (NIV) have 3.148, 8.159 and 26.456 times likelihood to be admitted to ICU, respectively. Patients with high CO-RADS, low oxygen saturation (less than 92.5%), and in need for mechanical ventilation (MV) have 82.8, 15.9, and 240.77 times likelihood to die, respectively. Conclusion: Initially asymptomatic hospitalized patients with COVID-19 have a great impact on health system with high ICU admission and mortality rate. We identified the predictors that may help in early management and improving prognosis. Trial registration: Trial was registered in Clinicaltrials.gov, registration number is NCT05298852, 26 March 2022, retrospectively registered.

  • Open Access

    Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients

    by Maged Mohamed Refaat, Riham Hazem Raafat, Heba Eid AbuAlia, Dina Sayed Sheha

    Introduction: Asthma is a heterogenous disease with various phenotypes that is characterized by airway limitation due to bronchospasm and airway inflammation associated with excessive mucus secretion. Eosinophilic asthma subtype is described as a late onset asthma that presents with more severe respiratory symptoms, and with sputum eosinophilia ≥ 3%. In the current study, we aimed to identify the difference in the clinical and demographic characteristics between eosinophilic and non-eosinophilic asthma subtypes and to determine predictors of eosinophilic asthma. Materials and methods: One hundred bronchial asthma patients with age ≥ 18 years were divided into two groups according to sputum eosinophilia. All patients were subjected to medical history, Asthma Control Test (ACT), spirometry, serum IgE level, skin prick testing (SPT), and nasal endoscopy to detect nasal polyposis and allergic signs. Results: No statistical difference was found between eosinophilic and non-eosinophilic asthma patients regarding age, gender, and body mass index. Patients with sputum eosinophilia had more severe obstruction by spirometry, and positive SPT to food allergens, pollens, and latex with statistical significance (p values 0.001, 0.016, and 0.017 respectively). Additionally, patients with sputum eosinophilia had lower ACT score, higher serum IgE level and higher serum eosinophil count. Total IgE had the highest diagnostic accuracy for discrimination of sputum eosinophilia among asthma patients. Pollen allergy and the severity of airway obstruction by spirometry were independent predictors of eosinophilic asthma. Conclusion: Patients with eosinophilic asthma had more severe airway obstruction, lower ACT scores, higher serum IgE level, and serum eosinophil count. Pollen allergy and obstructive pattern by spirometry were independent predictors of eosinophilic asthma.

  • Open Access

    The Effect of Hemodialysis vintage on pulmonary functions in patients with End Stage Renal Disease

    by Hesham Atef Abouellail, Hussien Sayed Hussien, Riham Hazem Raafat, Ahmed Ibrahim El-Sayed Ibrahim

    Background: Chronic kidney disease (CKD) is an irreversible and progressive disorder characterized by loss of kidney function. CKD gradually progresses to end-stage renal disease (ESRD). ESRD patients eventually need renal replacement therapy via dialysis (subdivided into hemodialysis and peritoneal dialysis) or kidney transplantation in order to survive. Aim of the Work: To see the effect of hemodialysis vintage on pulmonary function in patients with ESRD in Ain-Shams University Hospitals. Methods: This was a prospective study at the Ain-Shams University hospitals for six month duration on patient with ESRD on regular dialysis, 100 patients were chosen for this study, divided into 2 groups each group consists of 50 patients. Incident group (on chronic hemodialysis for 1-6 months duration) and Prevalent group (on chronic hemodialysis for more than 2 years). Results: this study reveals that there was statistically higher indices among incident compared to prevalent hemodialysis research groups before and after hemodialysis as regards improved Pulmonary Functions. Conclusion: prevalent cases on hemodialysis sessions have been improved clinically as regards basal crepitations and lower limb edema but didn't improve significantly in comparison to incident cases as regards Pulmonary functions on the other hand incident cases have been improved as regards Pulmonary functions In a more significant manner then prevalent cases but didn't improve as regards clinical basis concerning lower limb edema and basal crepitations.

  • Open Access

    Outcomes of Peripheral Blood Eosinophilia in Hospitalized Exacerbations of COPD

    by Samar El Sharkawy, Riham Hazem Raafat, Reem Osama Mohamed Ahmed Qassem

    Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines define COPD as a disease state characterized by airflow limitation that is not fully reversible, is usually progressive, and is associated with an abnormal inflammatory response of the lungs to inhaled noxious particles or gases. Objective: To identify outcomes of patients with eosinophilic COPD exacerbations requiring hospital admission. Patients and Methods: This study is a prospective cohort study that was conducted on two groups of total 60 patients recruited from Ain Shams University hospitals between October 2019 and July 2020. Group 1: Eosinophilic COPD exacerbation if the peripheral blood eosinophil on admission is ≥ 200 cells/µL and/or ≥2% of the total leukocyte count Group 2: Non-eosinophilic COPD exacerbation if the peripheral blood eosinophil on admission is < 200 cells/µL and/or < 2% of the total leukocyte count. Results: There was significant high diagnostic performance in predicting readmission at 6-month among eosinophilic group. Eosinophils count, percent (%) and NLR cutoff points had high characteristics (highest in NLR ≥3.1 at discharge) in predicting readmission at 6-month among eosinophilic group. Diagnostic performance of Eosinophils count, percent (%) and NLR were assessed. Eosinophils count, percent (%) and NLR had significant high diagnostic performance in predicting readmission at 6-month among eosinophilic group. Eosinophils count, % and NLR cutoff points had high characteristics (highest in NLR ≥2.1 at discharge) in predicting readmission at 6month among non-eosinophilic group. Conclusion: Eosinophils can be used as a prognostic marker in non-infective COPD exacerbations. Validity of eosinophil count and percent as a prognostic parameter in COPD exacerbation can be increased by combining with other parameters for example NLR.

  • Open Access

    Level of asthma control and mental health of asthma patients during lockdown for COVID-19: a cross-sectional survey

    by Dina S. Sheha, Asmaa S. Abdel-Rehim, Osama M. Abdel-Latif, Maryam A. Abdelkader, Riham H. Raafat, Sarah A. Sallam, Nayera S. Mostafa

    Background: Lockdown has been enforced globally to curb the spread of SARS-CoV-2. Patients with uncontrolled asthma are at risk of severe illness from COVID-19, highlighting the priority of adequate asthma control during the pandemic. Staying indoors exposes asthmatics to indoor asthma triggers, including disinfectants used for limiting the virus spread, in addition to psychological stresses of the pandemic which represent crucial contributors to loss of asthma control. Elective medical care, curtailed by the lockdown procedures, compromises adequate asthma follow up. The current study evaluated the effect of COVID-19 lockdown on the level of asthma control and mental health of bronchial asthma patients. The study included 264 bronchial asthma patients, aged 12 years and older, who responded to an online questionnaire including the asthma control test to evaluate asthma control in the preceding 4 weeks. Anxiety and depression scores and the impact of event scale were also provided. Results: Seventy percent of asthmatics had uncontrolled asthma, and disinfectant use was associated with perceived increase in asthma symptoms in 77.7%. Anxiety and depression were associated with uncontrolled asthma in 50% of participants, suggesting a possible psychological impact on asthma patients. Conclusions: During lockdown, asthma patients participating in the study had significantly uncontrolled disease and associated anxiety and depression. Since regular follow-up of asthma patients is cornerstone to adequate asthma control, alternative methods of medical care for asthma patients during lockdown are warranted, and particular need for mental health support ought to be provided as a continuum to adequate asthma control.